Seneca Growth Capital VCT Plc (HYG) Ordinary 1p
Sell:8.00p
Buy:15.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:8.00p
Buy:15.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:8.00p
Buy:15.00p
Change:
No change
No change
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
11.50p
11.50p
Trade high:
n/a
n/a
Year high:
15.80p
15.80p
Estimated NAV:
17.90
17.90
Previous close:
11.50p
11.50p
Trade low:
n/a
n/a
Year low:
8.00p
8.00p
Premium/Discount:
-35.75%
-35.75%
Previous:
0.00p (0.00%) Previous:
0.00p
0.00p (0.00%) Previous:
0.00p
Volume:
n/a
n/a
Dividend yield:
n/a
n/a
Currency:
GBX
GBX
Data delayed by at least 15 minutes.
Price
-
Net Asset Value (NAV)
Performance
Not available for this stock.
Trust Basics
| Benchmark: | FTSE All Share TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | Yes |
| Ongoing charge: | 1.74% |
| Dividend yield: | n/a |
| Dividend frequency: | Semi-Annually |
| Total assets: | £2m |
| Gross gearing: | 0% |
| Market capitalisation:Market cap.: | £1m |
| Shares in issue: | 31.62 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0031256109 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
The objective of Company has to date been to provide shareholders with an attractive income and capital return by investing its funds in a portfolio of unquoted and AIM/AQSE quoted UK companies which meet the relevant criteria under the VCT Rules. The Company will target well managed businesses with strong leadership, that can demonstrate established and proven concepts, and are seeking an injection of growth capital to support their continued development.
NET ASSET VALUE (NAV)
| Estimated NAV: | 17.90p |
|---|---|
| Latest actual NAV: | 17.90p |
| Latest actual NAV date: | 30 June 2024 |
| Premium/Discount: | -35.75% |
| 12m average Premium/Discount: | -27.25% |
| NAV frequency: | Quarterly |
| Security | Weight |
|---|---|
| Scancell Holdings plc Ord GBP0.001 | 57.83% |
| Arecor Therapeutics plc ORD GBP0.01 | 29.60% |
| Insense Limited | 4.99% |
| Fuel 3d Technologies Limited | 4.86% |
| Sector | Weight |
|---|---|
| Healthcare | 87.43% |
| Country | Weight |
|---|---|
| United Kingdom | 87.43% |
Key Dates
| Launch date: | 19 April 2002 |
|---|---|
| Financial year end: | December |
| Next AGM: | May 2025 |
Data policy -
All information should be used for indicative purposes only. You should independently
check data before making any investment decision. HL cannot guarantee that the data is
accurate or complete, and accepts no responsibility for how it may be used.
Prices provided by NBTrader. Charts provided by Factset.
Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics,
holding data, key dates, objective and NAV provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.